Diagnosis and treatment of blastomycosis affecting the nose and nasopharynx of a dog

J Am Vet Med Assoc. 2008 Oct 1;233(7):1112-6. doi: 10.2460/javma.233.7.1112.

Abstract

Case description: A 2-year-old 38.9-kg (85.58-lb) sexually intact male German Shepherd Dog was examined because of a 4-month history of severe nasal swelling and nasal mucosa congestion. The signs were slowly progressive.

Clinical findings: Physical examination revealed that the dorsal aspect of the dog's nose was swollen and hard. Mucous membranes in both nostrils were hyperemic and edematous. Diagnostic investigation revealed severe nasal osteolysis and pyogranulomatous rhinitis and nasopharyngitis attributable to blastomycosis.

Treatment and outcome: Oral administration of itraconazole was initiated (5 mg/kg [2.27 mg/lb], q 12 h for 5 days and then q 24 h). After a treatment period of 3 months, the nose had regained its normal appearance. After 5 months of treatment, the Blastomyces infection was eliminated as confirmed by results of rhinoscopy and biopsy specimen examination. No relapse was evident within 1 year after discontinuation of treatment.

Clinical relevance: In dogs, nasal and nasopharyngeal blastomycosis can result in severe osteolysis of the nasal bone. Resolution of disease can be achieved with oral administration of itraconazole for a period of at least 5 months.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Antifungal Agents / therapeutic use*
  • Blastomycosis / diagnosis
  • Blastomycosis / drug therapy
  • Blastomycosis / veterinary*
  • Dog Diseases / diagnosis*
  • Dog Diseases / drug therapy*
  • Dogs
  • Itraconazole / therapeutic use*
  • Male
  • Nasopharyngeal Diseases / diagnosis
  • Nasopharyngeal Diseases / drug therapy
  • Nasopharyngeal Diseases / microbiology
  • Nasopharyngeal Diseases / veterinary
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Itraconazole